| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |